Analyst
Oppenheimer
Equibles does not estimate personal net worth.
Steven Lichtman is recorded as Analyst at Oppenheimer. Steven Lichtman has spoken on 4 earnings calls across 2 companies, most recently for Dexcom Inc on July 30, 2025. Those appearances were for Dexcom Inc (DXCM) and Insulet Corp (PODD). The companies whose calls Steven Lichtman spoke on are classified in the Healthcare sector.
“I want to circle back on the international beat in the quarter and outlook. How would you have us think about the underlying international growth outlook here in the near to medium term?”
“You talked about the continued progress in type 2, and you highlighted the expanded commercial sales force. Can you double click on the DTC efforts? How deep are you into that work?”
“Just building on Stello, you had ADA last year. You talked purposely about focusing the Stello messaging on the non-insulin type 2 first.”
Oppenheimer
Analyst
Source not stated
DXCM
Medical Devices · Healthcare
PODD
Medical Devices · Healthcare
